University of California, Santa Barbara
Santa Barbara, California, United States
Purpose
to evaluate the enzymatic options for lowering the cost of the HIV anti-retroviral MK-8527 active pharmaceutical ingredient synthesis, which fill facilitate the future generic market entry of MK-8527 for low and middle income countries
Division
Global Health
Date
March 2025
Region Served
GLOBAL
Committed amount
$500,000
Grant topic
Development of Solutions to Improve Global Health, HIV
Duration (months)
27
Grantee location
Santa Barbara, California, United States
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.